ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 391,61
-0,38%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Vor Biopharma Inc (VOR) Cours

Vor Biopharma Inc

Vor Biopharma Inc (VOR)

Vortiv Limited
0,8673
-0,0194
(-2,19%)
À la fermeture: 21 Décembre 10:00PM
Retardé de 15 minutes
0,8673
-0,0038
( -0,44% )
Après les heures de négociation: 10:16PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,8673
Prix Achat
0,86
Prix Vente
0,90
Volume échangé
228 733
0,8443 Fourchette du Jour 0,8817
0,63 Plage de 52 semaines 3,1399
Cap du marché
59,561M
Clôture Veille
0,8867
Ouverture
0,877499
Dernière Transaction
7
@
0.9
Dernière heure de transaction
Volume financier
US$ 198 439
VWAP
0,867558
Volume moyen (3 m)
573 730
Actions en circulation
68 673 612
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,51
Bénéfice par action (BPA)
-1,72
Chiffre d'affairess
-
Bénéfice net
-117,86M

À propos de Vor Biopharma Inc

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.vorbio.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Vor Biopharma Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker VOR. Le dernier cours de clôture d'Vor Biopharma était de US$0,89. Au cours de la dernière année, les actions de Vor Biopharma ont été négociées dans une fourchette de prix de US$ 0,63 à US$ 3,1399.

Vor Biopharma compte actuellement 68 673 612 actions en circulation. La capitalisation boursière d'Vor Biopharma est de US$60,89 million. Vor Biopharma a un ratio cours/bénéfice (ratio PE) de -0.51.

VOR Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

09 Décembre 2024
Edgar (US Regulatory)

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

09 Décembre 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...

12 Novembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

08 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 Novembre 2024
Edgar (US Regulatory)

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed...

07 Novembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1327-13.2711.030.83013330580.95679883CS
40.079610.10537006470.78771.10.76015882710.93687921CS
120.112614.91983569630.75471.10.635737300.82867073CS
26-0.3227-27.11764705881.191.270.636756410.89143753CS
52-1.5527-64.16115702482.423.13990.634820901.19315325CS
156-11.9777-93.247956403312.84513.5250.632500542.53989477CS
260-41.1527-97.935982865342.0263.620.632316336.54269444CS

VOR - Frequently Asked Questions (FAQ)

What is the current Vor Biopharma share price?
The current share price of Vor Biopharma is US$ 0,8673
How many Vor Biopharma shares are in issue?
Vor Biopharma has 68 673 612 shares in issue
What is the market cap of Vor Biopharma?
The market capitalisation of Vor Biopharma is USD 60,89M
What is the 1 year trading range for Vor Biopharma share price?
Vor Biopharma has traded in the range of US$ 0,63 to US$ 3,1399 during the past year
What is the PE ratio of Vor Biopharma?
The price to earnings ratio of Vor Biopharma is -0,51
What is the reporting currency for Vor Biopharma?
Vor Biopharma reports financial results in USD
What is the latest annual profit for Vor Biopharma?
The latest annual profit of Vor Biopharma is USD -117,86M
What is the registered address of Vor Biopharma?
The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vor Biopharma website address?
The website address for Vor Biopharma is www.vorbio.com
Which industry sector does Vor Biopharma operate in?
Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
119,79M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
76,48M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
33,93M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,34k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
120,25M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,61M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,69M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,91M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,25M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,24M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
350,18M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
304,41M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
288,9M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
286,32M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,24M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
VOR
Vor Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés